Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection

Dig Liver Dis. 2020 Dec;52(12):1410-1412. doi: 10.1016/j.dld.2020.10.001. Epub 2020 Oct 6.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Review

MeSH terms

  • COVID-19 / mortality*
  • COVID-19 / physiopathology
  • Hospital Mortality
  • Humans
  • Proton Pump Inhibitors / therapeutic use*
  • Risk Factors
  • Severity of Illness Index

Substances

  • Proton Pump Inhibitors